共 6 条
[1]
Fagerholm P, Bjorklund H, Holmberg A, Et al., Heparin surface modified lenses implanted in the monkey eye, J Cataract Refract Surg, 15, pp. 485-490, (1989)
[2]
Spangberg M, Kihlstrom I, Bjorklund H, Et al., Improved biocompatibility of intraocular lenses by heparin surface modification: a 12-month implantation study in monkeys, J Cataract Refract Surg, 16, pp. 170-177, (1990)
[3]
Ygge J, Wenzel M, Philipson B, Fagerholm P, Cellular reactions on heparin surface-modified versus regular PMMA lenses during the first postoperative month: a double-masked and randomized study using specular microphotography, Ophthalmology, 97, pp. 1216-1223, (1990)
[4]
Larm O, Larsson R, Olsson P, A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue, Biomater Med Devices Artif Organs, 11, pp. 161-173, (1983)
[5]
Larsson R, Selen G, Bjorklund H, Fagerholm P, Intraocular PMMA lenses modified with surface-immobilized heparin: evaluation of biocompatibility in vitro and in vivo, Biomaterials, 10, pp. 511-516, (1989)
[6]
Pejler G, Lindahl U, Larm O, Et al., Monoclonal antibodies specific for oligosaccharides prepared by partial nitrous acid deamination of heparin, J Biol Chem, 263, pp. 5197-5201, (1988)